Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people

Open access

Abstract

BACKGROUND: The contemporary associations of type 2 diabetes with a wide range of incident cardiovascular diseases have not been compared. We aimed to study associations between type 2 diabetes and 12 initial manifestations of cardiovascular disease. METHODS: We used linked primary care, hospital admission, disease registry, and death certificate records from the CALIBER programme, which links data for people in England recorded in four electronic health data sources. We included people who were (or turned) 30 years or older between Jan 1, 1998, to March 25, 2010, who were free from cardiovascular disease at baseline. The primary endpoint was the first record of one of 12 cardiovascular presentations in any of the data sources. We compared cumulative incidence curves for the initial presentation of cardiovascular disease and used Cox models to estimate cause-specific hazard ratios (HRs). This study is registered at ClinicalTrials.gov (NCT01804439). FINDINGS: Our cohort consisted of 1 921 260 individuals, of whom 1 887 062 (98·2%) did not have diabetes and 34 198 (1·8%) had type 2 diabetes. We observed 113 638 first presentations of cardiovascular disease during a median follow-up of 5·5 years (IQR 2·1-10·1). Of people with type 2 diabetes, 6137 (17·9%) had a first cardiovascular presentation, the most common of which were peripheral arterial disease (reported in 992 [16·2%] of 6137 patients) and heart failure (866 [14·1%] of 6137 patients). Type 2 diabetes was positively associated with peripheral arterial disease (adjusted HR 2·98 [95% CI 2·76-3·22]), ischaemic stroke (1·72 [1·52-1·95]), stable angina (1·62 [1·49-1·77]), heart failure (1·56 [1·45-1·69]), and non-fatal myocardial infarction (1·54 [1·42-1·67]), but was inversely associated with abdominal aortic aneurysm (0·46 [0·35-0·59]) and subarachnoid haemorrhage (0·48 [0·26-0.89]), and not associated with arrhythmia or sudden cardiac death (0·95 [0·76-1·19]). INTERPRETATION: Heart failure and peripheral arterial disease are the most common initial manifestations of cardiovascular disease in type 2 diabetes. The differences between relative risks of different cardiovascular diseases in patients with type 2 diabetes have implications for clinical risk assessment and trial design. FUNDING: Wellcome Trust, National Institute for Health Research, and Medical Research Council.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(14)70219-0

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Distribution of initial presentations of cardiovascular diseases Distribution of initial presentations of cardiovascular disease in participants with and without type 2 diabetes and no history of cardiovascular disease.
Figure 1 Distribution of initial presentations of cardiovascular diseases Distribution of initial presentations of cardiovascular disease in participants with and without type 2 diabetes and no history of cardiovascular disease.CC BY-NC-ND · PubMed Central
Figure 2 Cumulative incidence curves for the incidence of first presentation of 12 cardiovascular diseases in patients aged ≥40 years, by diabetes status The curves begin at age 40 years rather than 30 years because 40 years is a typical age for a patient to develop type 2 diabetes.
Figure 2 Cumulative incidence curves for the incidence of first presentation of 12 cardiovascular diseases in patients aged ≥40 years, by diabetes status The curves begin at age 40 years rather than 30 years because 40 years is a typical age for a patient to develop type 2 diabetes.CC BY-NC-ND · PubMed Central
Figure 3 Association of type 2 diabetes with 12 cardiovascular diseases in patients aged ≥30 years Adjusted hazard ratios (HRs) for different initial presentations of cardiovascular diseases associated with type 2 diabetes, adjusted for age, sex, BMI, deprivation, HDL cholesterol, total cholesterol, systolic blood pressure, smoking status, and statin and antihypertensive drug prescriptions. Two non-specific components of the primary endpoint are not shown in the figure for simplicity (they are inprecisely recorded versions of one of the 12 initial presentations): coronary disease not further specified, HR 1·58 (95% CI 1·45–1·73), p<0·0001; stroke not further specified 1·64 (1·48–1·81), p<0·0001.
Figure 3 Association of type 2 diabetes with 12 cardiovascular diseases in patients aged ≥30 years Adjusted hazard ratios (HRs) for different initial presentations of cardiovascular diseases associated with type 2 diabetes, adjusted for age, sex, BMI, deprivation, HDL cholesterol, total cholesterol, systolic blood pressure, smoking status, and statin and antihypertensive drug prescriptions. Two non-specific components of the primary endpoint are not shown in the figure for simplicity (they are inprecisely recorded versions of one of the 12 initial presentations): coronary disease not further specified, HR 1·58 (95% CI 1·45–1·73), p<0·0001; stroke not further specified 1·64 (1·48–1·81), p<0·0001.CC BY-NC-ND · PubMed Central
Figure 4 Hazard ratios for association of type 2 diabetes with 12 cardiovascular diseases by sex and age Hazard ratios by sex and age group for the association of different initial presentations of cardiovascular disease with type 2 diabetes, adjusted for age, BMI, deprivation, HDL cholesterol, total cholesterol, systolic blood pressure, smoking status, and statin and antihypertensive drug prescriptions. NA=not applicable.
Figure 4 Hazard ratios for association of type 2 diabetes with 12 cardiovascular diseases by sex and age Hazard ratios by sex and age group for the association of different initial presentations of cardiovascular disease with type 2 diabetes, adjusted for age, BMI, deprivation, HDL cholesterol, total cholesterol, systolic blood pressure, smoking status, and statin and antihypertensive drug prescriptions. NA=not applicable.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 1,225

Metadata

Authors
Shah, A. D., Langenberg, C., Rapsomaniki, E., Denaxas, S., Pujades-Rodriguez, M., Gale, C. P., Deanfield, J., Smeeth, L., Timmis, A., & Hemingway, H.
Affiliations
  • Farr Institute (GB)
  • University of Cambridge (GB)
  • University of Leeds (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Queen Mary University of London (GB)
Corresponding author
Shah, Anoop Dinesh
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2015-02
Volume
3
Issue
2
Pages
105-113
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2150561315
Cited by
1,225
References
31
Citations by year
2026: 67 · 2025: 91 · 2024: 128 · 2023: 151 · 2022: 132 · 2021: 129 · 2020: 140 · 2019: 108 · 2018: 88 · 2017: 98 · 2016: 56 · 2015: 34
FWCI
50.68
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
Funders
  • National Institute for Health Research (RP-PG-0407-10314, PI HH, NIHR/CS/009/004)
  • Wellcome Trust (WT 086091/Z/08/Z, PI HH, 098504)
  • Medical Research Prognosis Research Strategy Partnership (G0902393/99558, PI HH)
  • The Medical Research Council (K006584/1, PI HH)
  • Wellcome Trust clinical research training fellowship (0938/30/Z/10/Z)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, cardiovascular disease incidence, peripheral arterial disease, heart failure, ischemic stroke, stable angina, myocardial infarction, abdominal aortic aneurysm, subarachnoid hemorrhage, cardiovascular risk stratification, cause-specific hazard ratio, cumulative incidence curves
MeSH terms
Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Cohort Studies, Incidence, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. https://app.cochat.ai/papers/10.1016/s2213-8587(14)70219-0
The paper
Shah, A. D., Langenberg, C., Rapsomaniki, E., Denaxas, S., Pujades-Rodriguez, M., Gale, C. P., Deanfield, J., Smeeth, L., Timmis, A., & Hemingway, H. (2015). Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(14)70219-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.